Skip to main content

toppbild-investerare-1551x278.jpg

Exercise of warrants

Information regarding exercise of warrants of series 2020:1 in Moberg Pharma AB

The Board of directors of Moberg Pharma AB (publ) (“Moberg” or the “Company”) resolved on 6 November 2020, subject to the approval of the extraordinary general meeting to be held on 1 December 2020, to carry out a fully guaranteed rights issue of not more than 23,175,576 units at the issue price of SEK 6.47 per unit. Each unit consists of one (1) ordinary share and one (1) warrant free of change.

The warrants were issued free of charge and can be exercised for subscription of new shares during the period 16 March - 29 March 2022. Two (2) warrants entitle the holder to subscribe for one (1) new ordinary share in the Company. The warrants of series 2020:1 will cease to be traded on 25 March 2022. In order for your warrants not to expire, your action is required. You must apply for subscription for new shares, by exercise of warrants, no later than on 29 March 2022.

Terms in brief

  • Two (2) warrants entitles to subscription of one (1) ordinary share in Moberg Pharma during the period 16 March – 29 March 2022.
  • The subscription price has been set at SEK 6.47 per share.
  • The warrants have ISIN code SE0015195524 and are subject to trading on Nasdaq Stockholm.
  • The last day for trading in the warrants is 25 March 2022.

Full terms and conditions regarding the warrants and information about the Company are available in the prospectus approved by the Swedish Financial Supervisory Authority and published by the Company on 3 December 2020. Link Full terms and conditions for the warrants. Link

If your warrants are nominee registered

Subscription and payment of new shares, by exercise of warrants, shall be made to the account-holding bank/nominee with which the warrants are registered. The subscription and payment shall be made in accordance with instructions from each such bank or nominee. Usually, the bank/nominee sends out a digital notice to the account holder, otherwise it is enough to log into the securities custody account from the first day in the exercise period in order to get instructions on how to exercise warrants for subscription of new shares. If you do not find these instructions, please contact your bank or trustee. Please note that banks and other nominees may set different time limits for the last day for subscription, hence it is recommended to contact the account-holding bank/nominee early in the exercise period. Shares subscribed and paid for may be entered as “interim shares” or “IA” into your securities custody account until registration of the new shares is completed with the Swedish Companies Registration Office, whereby interim shares will automatically be converted to ordinary shares in Moberg Pharma.

If your warrants are directly registered

Subscription of new shares, by exercise of warrants, shall be made by sending a completed subscription form to Hagberg & Aneborn AB. In conjunction with sending the completed subscription form, payment must be made to Hagberg & Aneborn AB in accordance with the payment details stated on the subscription form. Completed subscription form and payment must be registered with Hagberg & Aneborn AB no later than on 29 March 2022. Shares subscribed and paid for will be entered as “interim shares” (“IA”) into your VP-account until registration of the new shares is completed with the Swedish Companies Registration Office, whereby interim shares will automatically be converted to ordinary shares in Moberg Pharma.

Important dates for warrants of series 2020:1

NOTE - In order for your warrants not to expire worthless, you must actively subscribe and pay for shares no later than 29 March 2022, or alternatively sell your warrants no later than 25 March 2022.

28 February - 11 March 2022: determination of subscription price with “VWAP” (Volume Weighted Average Price), however according to the higher of (i) SEK 6.47 (subscription price in the Rights Issue), and (ii) 70 percent of the average volume-weighted payment price for the Company's ordinary share on Nasdaq Stockholm. Subscription price set at SEK 6.47 per share.

16 March 2022: The exercise period begins

25 March 2022: Last day of trading in the warrants

29 March 2022: The exercise period ends

31 March 2022: Planned date for publication of warrant exercise outcome

Around 19 April 2022: Planned date for conversion of interim shares into shares

Q&A

1. What does the warrant mean?

In the rights issue, which was announced on November 6, 2020, the Board of Directors of Moberg Pharma decided on a fully guaranteed new issue of ordinary shares and warrants with preferential rights for existing shareholders. Two warrants give the right (but not the obligation) to subscribe for a new share during the period 16 - 29 March 2022.
 

2. What is the subscription price for the warrants?

SEK 6.47.
 

3. Is it possible to trade with the warrants?

Yes, since January 22, 2021, the warrants are traded on Nasdaq Stockholm. The warrants have ISIN code: SE0015195524.
 

4. How many warrants are there?

                               There are 23,175,576 outstanding warrants.
 

5. What is the last day to sell warrants so that they do not expire worthless?

                              The last day for trading in the warrants is March 25, 2022.
 

6. When is the deadline for subscribing for shares with the support of warrants?

                               March 29, 2022, at 3 p.m. 
 

7. Where can I find more information?

                              Further information is available in the Prospectus from 3 December 2020. Link Full terms and conditions for the warrants. Link